Skip to main content

Table 1 Patient characteristics

From: Effect of dexmedetomidine on inflammation in patients with sepsis requiring mechanical ventilation: a sub-analysis of a multicenter randomized clinical trial

Characteristic

DEX group (n = 100)

Non-DEX group (n = 101)

P value

Age (years), mean (SD)

68 (14.9)

69 (13.6)

0.75

Men, n (%)

63 (63)

64 (63)

0.96

Body weight (kg), mean (SD)

55 (12.5)

58 (15.3)

0.09

COPD, n (%)

8 (8)

9 (9)

0.82

Soft tissue infection, n (%)

8 (8)

10 (10)

0.64

Emergency surgery, n (%)

37 (37)

36 (36)

0.84

Site of infection, n (%)

 Abdomen

39 (39)

35 (35)

0.52

 Thorax

39 (39)

33 (33)

0.35

 Urinary tract

6 (6)

10 (10)

0.31

 Pancreatitis

3 (3)

9 (9)

0.13

 Skin and soft tissue

6 (6)

7 (7)

0.79

 Central nervous system

1 (1)

1 (1)

1.00

 Others

6 (6)

6 (6)

0.99

APACHE II score, median [IQR]

23 [18, 29]

22 [16, 29.5]

0.51

SOFA score, median [IQR]

8 [6, 11]

9 [5, 11]

0.67

SOFA respiratory score, median [IQR]

2 [1, 3]

2 [1, 3]

0.86

SOFA circulatory score, median [IQR]

3 [2, 4]

3 [1.5, 4]

0.44

SOFA renal score, median [IQR]

1 [0, 2]

1 [0, 3]

0.28

SOFA hepatic score, median [IQR]

0 [0, 1]

0 [0, 1]

0.42

SOFA neurological score, median [IQR]

1 [0, 2]

0 [0, 3]

0.87

SOFA coagulation score, median [IQR]

0 [0, 2]

1 [0, 2]

0.26

CRP (mg/dL), median [IQR]

13.8 [6.0, 25.7]

16.8 [6.4, 25.8]

0.64

PCT (ng/mL), median [IQR]

15.2 [2.8, 44.9]

14.6 [1.5, 81.5]

0.70

ALB (g/dL), mean (SD)

2.6 (0.7)

2.7 (0.7)

0.64

PLT (109/L), median [IQR]

170 [98, 227]

141 [95, 224]

0.34

PT (INR), median [IQR]

1.21 [1.06, 1.37]

1.24 [1.08, 1.45]

0.34

FDPs (mcg/mL), median [IQR]

16.0 [7.8, 29.3]

17.4 [8.8, 33.5]

0.80

SIRS criteria ≥ 3, n (%)

71 (71)

75 (74)

0.60

DIC, n (%)

40 (40)

42 (42)

0.87

  1. Abbreviations: DEX dexmedetomidine, COPD chronic obstructive pulmonary disease, APACHE II Acute Physiology and Chronic Health Evaluation II, IQR interquartile range, SOFA Sequential Organ Failure Assessment, SD standard deviation, CRP C-reactive protein, PCT procalcitonin, ALB albumin, PLT platelet, PT-INR prothrombin time-international ratio, FDPs fibrin/fibrinogen degradation products, SIRS systemic inflammatory response syndrome, DIC disseminated intravascular coagulation